Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine
Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), shows variable efficacy, particularly among adolescents and adults, underscoring the pressi...
Uložené v:
| Vydané v: | European journal of pharmaceutical sciences Ročník 205; s. 106995 |
|---|---|
| Hlavní autori: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Netherlands
Elsevier B.V
01.02.2025
|
| Predmet: | |
| ISSN: | 0928-0987, 1879-0720, 1879-0720 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), shows variable efficacy, particularly among adolescents and adults, underscoring the pressing need for more effective vaccination strategies. The administration route is crucial for vaccine efficacy, and administration via the skin, being rich in immune cells, may offer advantages over conventional subcutaneous routes, which lack direct access to abundant antigen-presenting cells.
This study compared the immunogenic effects of intradermal versus subcutaneous administration of a candidate TB vaccine delivering a Ag85B-ESAT6-Rv2034 (AER) multiphase fusion recombinant protein, in lipid-poly(D,L-lactic-co-glycolic acid) (lipid-PLGA) nanoparticles in mice. In-depth evaluation of immune responses in splenocytes was performed using 27-marker spectral flow cytometry. Both routes elicited significant T-cell responses. However, intradermal administration uniquely increased polyfunctional CD4+ and CD8+ T-cells producing IL-2, IFNγ, and TNFα, associated with protection against TB. Additionally, it significantly increased CD69+ B-cell counts and induced higher AER-specific antibody titers, particularly IgG2a. These results underscore the superior immunogenic potential of intradermal vaccine administration by effectively inducing immune cells associated with TB protection, highlighting its significance in the development of new vaccine strategies.
[Display omitted] |
|---|---|
| AbstractList | Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), shows variable efficacy, particularly among adolescents and adults, underscoring the pressing need for more effective vaccination strategies. The administration route is crucial for vaccine efficacy, and administration via the skin, being rich in immune cells, may offer advantages over conventional subcutaneous routes, which lack direct access to abundant antigen-presenting cells. This study compared the immunogenic effects of intradermal versus subcutaneous administration of a candidate TB vaccine delivering a Ag85B-ESAT6-Rv2034 (AER) multiphase fusion recombinant protein, in lipid-poly(D,L-lactic-co-glycolic acid) (lipid-PLGA) nanoparticles in mice. In-depth evaluation of immune responses in splenocytes was performed using 27-marker spectral flow cytometry. Both routes elicited significant T-cell responses. However, intradermal administration uniquely increased polyfunctional CD4
and CD8
T-cells producing IL-2, IFNγ, and TNFα, associated with protection against TB. Additionally, it significantly increased CD69
B-cell counts and induced higher AER-specific antibody titers, particularly IgG2a. These results underscore the superior immunogenic potential of intradermal vaccine administration by effectively inducing immune cells associated with TB protection, highlighting its significance in the development of new vaccine strategies. Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), shows variable efficacy, particularly among adolescents and adults, underscoring the pressing need for more effective vaccination strategies. The administration route is crucial for vaccine efficacy, and administration via the skin, being rich in immune cells, may offer advantages over conventional subcutaneous routes, which lack direct access to abundant antigen-presenting cells. This study compared the immunogenic effects of intradermal versus subcutaneous administration of a candidate TB vaccine delivering a Ag85B-ESAT6-Rv2034 (AER) multiphase fusion recombinant protein, in lipid-poly(D,L-lactic-co-glycolic acid) (lipid-PLGA) nanoparticles in mice. In-depth evaluation of immune responses in splenocytes was performed using 27-marker spectral flow cytometry. Both routes elicited significant T-cell responses. However, intradermal administration uniquely increased polyfunctional CD4+ and CD8+ T-cells producing IL-2, IFNγ, and TNFα, associated with protection against TB. Additionally, it significantly increased CD69+ B-cell counts and induced higher AER-specific antibody titers, particularly IgG2a. These results underscore the superior immunogenic potential of intradermal vaccine administration by effectively inducing immune cells associated with TB protection, highlighting its significance in the development of new vaccine strategies. [Display omitted] Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), shows variable efficacy, particularly among adolescents and adults, underscoring the pressing need for more effective vaccination strategies. The administration route is crucial for vaccine efficacy, and administration via the skin, being rich in immune cells, may offer advantages over conventional subcutaneous routes, which lack direct access to abundant antigen-presenting cells. This study compared the immunogenic effects of intradermal versus subcutaneous administration of a candidate TB vaccine delivering a Ag85B-ESAT6-Rv2034 (AER) multiphase fusion recombinant protein, in lipid-poly(D,L-lactic-co-glycolic acid) (lipid-PLGA) nanoparticles in mice. In-depth evaluation of immune responses in splenocytes was performed using 27-marker spectral flow cytometry. Both routes elicited significant T-cell responses. However, intradermal administration uniquely increased polyfunctional CD4+ and CD8+ T-cells producing IL-2, IFNγ, and TNFα, associated with protection against TB. Additionally, it significantly increased CD69+ B-cell counts and induced higher AER-specific antibody titers, particularly IgG2a. These results underscore the superior immunogenic potential of intradermal vaccine administration by effectively inducing immune cells associated with TB protection, highlighting its significance in the development of new vaccine strategies.Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), shows variable efficacy, particularly among adolescents and adults, underscoring the pressing need for more effective vaccination strategies. The administration route is crucial for vaccine efficacy, and administration via the skin, being rich in immune cells, may offer advantages over conventional subcutaneous routes, which lack direct access to abundant antigen-presenting cells. This study compared the immunogenic effects of intradermal versus subcutaneous administration of a candidate TB vaccine delivering a Ag85B-ESAT6-Rv2034 (AER) multiphase fusion recombinant protein, in lipid-poly(D,L-lactic-co-glycolic acid) (lipid-PLGA) nanoparticles in mice. In-depth evaluation of immune responses in splenocytes was performed using 27-marker spectral flow cytometry. Both routes elicited significant T-cell responses. However, intradermal administration uniquely increased polyfunctional CD4+ and CD8+ T-cells producing IL-2, IFNγ, and TNFα, associated with protection against TB. Additionally, it significantly increased CD69+ B-cell counts and induced higher AER-specific antibody titers, particularly IgG2a. These results underscore the superior immunogenic potential of intradermal vaccine administration by effectively inducing immune cells associated with TB protection, highlighting its significance in the development of new vaccine strategies. |
| ArticleNumber | 106995 |
| Author | Szachniewicz, M.M. Ottenhoff, T.H.M. Geluk, A. Franken, K.L.M.C. van Meijgaarden, K.E. van Veen, S. van den Eeden, S.J.F. Bouwstra, J.A. |
| Author_xml | – sequence: 1 givenname: M.M. orcidid: 0000-0003-3859-314X surname: Szachniewicz fullname: Szachniewicz, M.M. email: m.m.szachniewicz@lumc.nl organization: Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands – sequence: 2 givenname: S.J.F. surname: van den Eeden fullname: van den Eeden, S.J.F. organization: Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands – sequence: 3 givenname: K.E. surname: van Meijgaarden fullname: van Meijgaarden, K.E. organization: Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands – sequence: 4 givenname: K.L.M.C. surname: Franken fullname: Franken, K.L.M.C. organization: Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands – sequence: 5 givenname: S. surname: van Veen fullname: van Veen, S. organization: Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands – sequence: 6 givenname: A. surname: Geluk fullname: Geluk, A. organization: Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands – sequence: 7 givenname: J.A. surname: Bouwstra fullname: Bouwstra, J.A. organization: Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, The Netherlands – sequence: 8 givenname: T.H.M. surname: Ottenhoff fullname: Ottenhoff, T.H.M. organization: Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39710106$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUFv1DAQhS1URLeFP8AB-cgli504iY24VFUplVaCA5wtxxnDrBJ7sZ2V2n_Av8ZL2guHnkYzft-T_N4FOfPBAyFvOdtyxrsP-y3sD2lbs1qUQ6dU-4JsuOxVxfqanZENU7WsmJL9OblIac8Y62TPXpHzRvXFgXUb8ufO52hGiLOZ6BFiWhJNy2CXbDyEsuA8Lx4fTMbgP9Ib58DmRIOjZpzRYyr06YnGsGSgS0L_kxo64QHH6tvu9or-uh8ijtQbHw4mZrQT0LwMEO0yhYSJHo216OE1eenMlODN47wkPz7ffL_-Uu2-3t5dX-0qKxjLlRsUN8IwYV3TDIMzMA61MkqNotzBdC0XTnEOnXNqkEY0vZRStNDylivbNJfk_ep7iOH3AinrGZOFaVo_rBsupFBtya5I3z1Kl2GGUR8izibe66f4ikCuAhtDShGctpj_5VFiwUlzpk9N6b0-NaVPTem1qYLW_6FP7s9Cn1YISkBHhKiTRfAWRoylFz0GfA7_C2eKsEA |
| CitedBy_id | crossref_primary_10_3390_vaccines13090893 |
| Cites_doi | 10.1016/j.ejpb.2024.114437 10.1155/2012/745483 10.1001/jamanetworkopen.2020.35693 10.1084/jem.20230859 10.1016/j.celrep.2021.109696 10.1016/S0962-8479(97)90006-X 10.1016/j.vaccine.2012.10.045 10.1016/j.matdes.2020.108805 10.1016/j.jconrel.2016.01.050 10.1016/j.cell.2016.08.072 10.1016/j.jconrel.2017.12.003 10.1586/erv.11.17 10.1016/S0140-6736(06)68507-3 10.1172/JCI32933 10.1016/j.micinf.2005.12.004 10.1016/j.ejpb.2013.07.002 10.1016/j.molimm.2014.06.007 10.1006/prep.1999.1162 10.1021/acsami.6b01135 10.1128/IAI.73.9.6101-6109.2005 10.1371/journal.pone.0031472 10.1016/j.ejps.2024.106730 10.1046/j.1365-2249.1996.d01-845.x 10.4049/jimmunol.0801592 10.1128/IAI.00083-16 10.1086/314072 10.1111/j.1365-2036.2006.03002.x 10.4049/jimmunol.181.12.8595 10.15252/emmm.201606330 10.3390/pharmaceutics14122728 10.4049/jimmunol.1500792 10.1111/apm.12851 10.4049/jimmunol.1500981 10.1016/j.micpath.2017.08.040 10.2147/IJN.S40579 10.1016/j.smim.2018.05.003 10.1016/j.ejpb.2018.11.013 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4 10.1016/S0304-3959(99)00231-6 10.1089/aid.2012.0028 10.1164/rccm.200910-1484OC 10.1371/journal.pone.0061681 10.1016/j.tube.2023.102307 10.1016/j.intimp.2024.113782 10.1016/j.ajpath.2012.05.009 10.4049/jimmunol.178.11.7222 10.1038/nm.2299 10.1371/journal.ppat.1002607 10.1016/j.micpath.2018.10.023 10.1146/annurev-immunol-051116-052215 10.1002/cmdc.201200487 10.3389/fimmu.2014.00180 10.1016/j.tmaid.2021.102007 10.1002/9783527611614.ch23 10.1111/j.1365-3083.2011.02629.x 10.1038/nm.2285 10.1016/S0531-5565(00)00257-6 10.1111/j.1462-5822.2005.00612.x 10.4049/jimmunol.164.12.6417 10.4161/hv.34299 10.1016/j.drudis.2014.09.018 10.1128/IAI.73.11.7759-7764.2005 10.3389/fimmu.2021.640168 10.1371/journal.ppat.1005687 10.1016/j.ijpharm.2024.124842 10.4049/jimmunol.1003189 10.3389/fimmu.2017.01262 10.1128/CVI.00368-09 10.1016/j.tmaid.2020.101868 10.1016/S1473-3099(19)30625-5 10.4049/jimmunol.1201593 10.1111/srt.12576 10.1073/pnas.1611776114 |
| ContentType | Journal Article |
| Copyright | 2024 The Authors Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2024 The Authors – notice: Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ejps.2024.106995 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1879-0720 |
| ExternalDocumentID | 39710106 10_1016_j_ejps_2024_106995 S0928098724003087 |
| Genre | Journal Article Comparative Study |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 6I. 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAFTH AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABFRF ABJNI ABLJU ABMAC ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADVLN AEBSH AEFWE AEIPS AEKER AENEX AFJKZ AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AKRWK ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA GROUPED_DOAJ IHE J1W KOM MO0 N9A O-L O9- OAUVE OGGZJ OK1 OVD OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SSP SSZ T5K TEORI ~G- 29G 53G 5VS 9DU AAQXK AATTM AAYWO AAYXX ABFNM ABWVN ABXDB ACLOT ACRPL ACVFH ADCNI ADMUD ADNMO AEUPX AFPUW AGQPQ AIGII AIIUN AKBMS AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CITATION EFKBS EFLBG EJD FEDTE FGOYB G-2 HMT HVGLF HZ~ M34 M41 R2- SPT WUQ ~HD ADPDF AGCQF AGRNS BNPGV CGR CUY CVF ECM EIF NPM SSH 7X8 |
| ID | FETCH-LOGICAL-c400t-fb91a4a04cf33bbfaedb29a99d41a4ea6514f911e6ff9b8a43788845e51519c33 |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001394650900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0928-0987 1879-0720 |
| IngestDate | Sat Sep 27 19:27:56 EDT 2025 Mon Jul 21 05:47:30 EDT 2025 Tue Nov 18 22:35:31 EST 2025 Sat Nov 29 03:17:22 EST 2025 Sat Jan 18 16:09:27 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | NP Ag HRP MHC CpG ODN TNF Cationic lipid−PLGA hybrid nanoparticles IFN PDI Subunit vaccine FDR FBS pH Adjuvant TLR DOPC i.d KLRG1 DOPE Th1/Th2 UMAP CD DOBAQ BCG MDR-TB s.c IQR AER rpm TB Bacillus Calmette-Guérin Tuberculosis CCR PLGA Immunogenicity APC PE EPC Mtb CXCR Vaccine delivery system HLA LUMC MPLA PD-1 Ig PCR DC |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c400t-fb91a4a04cf33bbfaedb29a99d41a4ea6514f911e6ff9b8a43788845e51519c33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-3859-314X |
| OpenAccessLink | http://dx.doi.org/10.1016/j.ejps.2024.106995 |
| PMID | 39710106 |
| PQID | 3148495092 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3148495092 pubmed_primary_39710106 crossref_citationtrail_10_1016_j_ejps_2024_106995 crossref_primary_10_1016_j_ejps_2024_106995 elsevier_sciencedirect_doi_10_1016_j_ejps_2024_106995 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-02-01 |
| PublicationDateYYYYMMDD | 2025-02-01 |
| PublicationDate_xml | – month: 02 year: 2025 text: 2025-02-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | European journal of pharmaceutical sciences |
| PublicationTitleAlternate | Eur J Pharm Sci |
| PublicationYear | 2025 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Levin, Perrin, Combadiere (bib0035) 2015; 11 Cavalcanti, Brelaz, Neves, Ferraz, Pereira (bib0010) 2012 Szachniewicz, Neustrup, van Meijgaarden, Jiskoot, Bouwstra, Haks, Geluk, Ottenhoff (bib0065) 2024; 195 Alter, Ottenhoff, Joosten (bib0004) 2018; 39 Lindenstrøm, Agger, Korsholm, Darrah, Aagaard, Seder, Rosenkrands, Andersen (bib0040) 2009; 182 Szachniewicz, Neustrup, van den Eeden, van Meijgaarden, Franken, van Veen, Koning, Limpens, Geluk, Bouwstra, Ottenhoff (bib0064) 2024; 666 Woodworth, Wu, Behar (bib0075) 2008; 181 Phuah, Wong, Gideon, Maiello, Coleman, Hendricks, Ruden, Cirrincione, Chan, Lin, Flynn (bib0052) 2016; 84 You, Jiang, Wu, Yu, Chen, Zhang, Wei, Wang, Tang, Jiang, Wu, Wang, Meng, Zhao, Kong (bib0076) 2012; 75 Phuah, Mattila, Lin, Flynn (bib0053) 2012; 181 Fabrizi, Dixit, Magnini, Elli, Martin (bib0016) 2006; 24 Johnson, Cooper, Frank, Bonorino, Wysoki, Orme (bib0026) 1997; 78 Joosten, van Meijgaarden, del Nonno, Baiocchini, Petrone, Vanini, Smits, Palmieri, Goletti, Ottenhoff (bib0027) 2016; 12 Turner, Frank, Brooks, Gonzalez-Juarrero, Orme (bib0070) 2001; 36 Rose, Wern, Gavins, Andersen, Follmann, Foged (bib0057) 2018; 271 Szachniewicz, van den Eeden, van Meijgaarden, Franken, van Veen, Geluk, Bouwstra, Ottenhoff (bib0066) 2024; 203 Ghitman, Biru, Stan, Iovu (bib0019) 2020; 193 Lewinsohn, Lewinsohn, Scriba (bib0036) 2017; 8 R Core Team, 2023. R: A language and environment for statistical computing. Geluk, van den Eeden, van Meijgaarden, Dijkman, Franken, Ottenhoff (bib0018) 2012; 30 Kipnis, Irwin, Izzo, Basaraba, Orme (bib0033) 2005; 73 Bloom (bib0006) 2023; 220 Li, Deng, Li, Zeng, Zhao, Liu, Wang (bib0038) 2014; 62 Van Pinxteren, Cassidy, Smedegaard, Agger, Andersen (bib0071) 2000; 30 Giles, Kashgarian, Koni, Shlomchik (bib0020) 2015; 195 Khademi, Derakhshan, Yousefi-Avarvand, Najafi, Tafaghodi (bib0030) 2018; 125 Maglione, Xu, Chan (bib0045) 2007; 178 Commandeur, van Meijgaarden, Prins, Pichugin, Dijkman, van den Eeden, Friggen, Franken, Dolganov, Kramnik, Schoolnik, Oftung, Korsvold, Geluk, Ottenhoff (bib0012) 2013; 190 Lu, Barreira-Silva, Boyce, Powers, Cavallo, Behar (bib0044) 2021; 36 Witting, Svensson, Gottrup, Arendt-Nielsen, Jensen (bib0074) 2000; 84 Tsai, Chakravarty, Zhu, Xu, Tanaka, Koch, Tufariello, Flynn, Chan (bib0069) 2006; 8 Harari, Rozot, Enders, Perreau, Stalder, Nicod, Cavassini, Calandra, Blanchet, Jaton, Faouzi, Day, Hanekom, Bart, Pantaleo (bib0024) 2011; 3 Henao-Tamayo, Ordway, Irwin, Shang, Shanley, Orme (bib0025) 2010; 17 Lu, Chung, Rosebrock, Ghebremichael, Yu, Grace, Schoen, Tafesse, Martin, Leung, Mahan, Sips, Kumar, Tedesco, Robinson, Tkachenko, Draghi, Freedberg, Streeck, Suscovich, Lauffenburger, Restrepo, Day, Fortune, Alter (bib0043) 2016; 167 Abel, Tameris, Mansoor, Gelderbloem, Hughes, Abrahams, Makhethe, Erasmus, De Kock, Van Der Merwe, Hawkridge, Veldsman, Hatherill, Schirru, Pau, Hendriks, Weverling, Goudsmit, Sizemore, McClain, Goetz, Gearhart, Mahomed, Hussey, Sadoff, Hanekom (bib0002) 2012; 181 Lin, Rutledge, Green, Bigbee, Fuhrman, Klein, Flynn (bib0039) 2012; 28 Trunz, Fine, Dye (bib0068) 2006; 367 Egunsola, Clement, Taplin, Mastikhina, Li, Lorenzetti, Dowsett, Noseworthy (bib0015) 2021; 4 Hadinoto, Sundaresan, Cheow (bib0023) 2013; 85 . RStudio Team, 2023. RStudio: Integrated Development Environment for R. Torrado, Fountain, Robinson, Martino, Pearl, Rangel-Moreno, Tighe, Dunn, Cooper (bib0067) 2013; 8 Brewer (bib0009) 2000; 31 Li, Wang, Wang, Fu, Liu, Lu, Cao, Huang, Javid (bib0037) 2017; 114 Alsaab, Alharbi, Alhibs, Alanazi, Alshehri, Saleh, Alshehri, Algarni, Almugaiteeb, Uddin, Alzhrani (bib0003) 2022; 14 Christensen, Korsholm, Andersen, Agger (bib0011) 2011; 10 Khera, Afkhami, Lai, Jeyanathan, Zganiacz, Mandur, Hammill, Damjanovic, Xing (bib0032) 2015; 195 Karbalaei Zadeh Babaki, Soleimanpour, Rezaee (bib0028) 2017; 112 Liu, Cao, Liu, Wang, Zhang, Sun, Wang, Leng, Song, Kong, Ma (bib0041) 2016; 8 Sah, Thoma, Desu, Sah, Wood (bib0060) 2013; 8 Grace, Dolatshahi, Lu, Cain, Palmieri, Petrone, Fortune, Ottenhoff, Lauffenburger, Goletti, Joosten, Alter (bib0021) 2021; 12 Schrager, Vekemens, Drager, Lewinsohn, Olesen (bib0063) 2020; 20 Boom (bib0007) 2007; 117 Vordermeier, Venkataprasad, Harris, Ivanyi (bib0072) 2003; 106 Bosio, Gardner, Elkins (bib0008) 2000; 164 Roy, Stavropoulos, Brennan, Coade, Grigorieva, Walker, Dagg, Tascon, Lowrie, Colston, Jolles (bib0058) 2005; 73 Duong, Skwarczynski, Toth (bib0014) 2023; 139 Rijnink, Ottenhoff, Joosten (bib0056) 2021; 12 Ottenhoff, Kaufmann (bib0049) 2012; 8 Franken, Hiemstra, Van Meijgaarden, Subronto, Den Hartigh, Ottenhoff, Drijfhout (bib0017) 2000; 18 Balu, Reljic, Lewis, Pleass, McIntosh, van Kooten, van Egmond, Challacombe, Woof, Ivanyi (bib0005) 2011; 186 Prezzemolo, Guggino, La Manna, Di, Di, Dieli, Caccamo (bib0054) 2014; 5 Khademi, Sahebkar, Fasihi-Ramandi, Taheri (bib0031) 2018; 126 Szachniewicz, van Meijgaarden, Kavrik, Jiskoot, Bouwstra, Haks, Geluk, Ottenhoff (bib78) 2025; 145 Zimmermann, Thormann, Hu, Köhler, Imai-Matsushima, Locht, Arnett, Schlesinger, Zoller, Schürmann, Kaufmann, Wardemann (bib0077) 2016; 8 (bib0073) 2023 Kashem, Haniffa, Kaplan (bib0029) 2017; 35 Schnyder, De Pijper, Garcia Garrido, Daams, Goorhuis, Stijnis, Schaumburg, Grobusch (bib0061) 2020; 37 Aagaard, Hoang, Dietrich, Cardona, Izzo, Dolganov, Schoolnik, Cassidy, Billeskov, Andersen (bib0001) 2011; 2 Moyle, Toth (bib0047) 2013; 8 Schnyder, Garcia Garrido, De Pijper, Daams, Stijnis, Goorhuis, Grobusch (bib0062) 2021; 41 Pandita, Kumar, Lather (bib0051) 2015; 20 Ogai, Nonaka, Toda, Ono, Minegishi, Inou, Hachiya, Fukamizu (bib0048) 2018; 24 Moon, Suh, Polhemus, Ockenhouse, Yadava, Irvine (bib0046) 2012; 7 Guirado, Amat, Gil, Díaz, Arcos, Caceres, Ausina, Cardona (bib0022) 2006; 8 Leone, Priester, Romeijn, Nejadnik, Mönkäre, O'Mahony, Jiskoot, Kersten, Bouwstra (bib0034) 2019; 134 Ottenhoff, T.H.M., Lewinsohn, D.A., Lewinsohn, D.M., 2008. Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis: Antigen Specificity, Function, Implications and Applications. Handbook of Tuberculosis 119–155. Davies, Wang, Steigler, Bowman, Fischinger, Hatherill, Fisher, Mbandi, Rodo, Ottenhoff, Dockrell, Sutherland, Mayanja-Kizza, Boom, Walzl, Kaufmann, Nemes, Scriba, Lauffenburger, Alter, Fortune (bib0013) 2024; 2024 Liu, Ma, Wang, Zhang, Sun, Wang, Song, Leng, Kong, Ma (bib0042) 2016; 225 Duong (10.1016/j.ejps.2024.106995_bib0014) 2023; 139 Pandita (10.1016/j.ejps.2024.106995_bib0051) 2015; 20 Alsaab (10.1016/j.ejps.2024.106995_bib0003) 2022; 14 Bloom (10.1016/j.ejps.2024.106995_bib0006) 2023; 220 Khera (10.1016/j.ejps.2024.106995_bib0032) 2015; 195 Szachniewicz (10.1016/j.ejps.2024.106995_bib0065) 2024; 195 Brewer (10.1016/j.ejps.2024.106995_bib0009) 2000; 31 Karbalaei Zadeh Babaki (10.1016/j.ejps.2024.106995_bib0028) 2017; 112 Phuah (10.1016/j.ejps.2024.106995_bib0053) 2012; 181 Abel (10.1016/j.ejps.2024.106995_bib0002) 2012; 181 Kipnis (10.1016/j.ejps.2024.106995_bib0033) 2005; 73 Cavalcanti (10.1016/j.ejps.2024.106995_bib0010) 2012 Rose (10.1016/j.ejps.2024.106995_bib0057) 2018; 271 Liu (10.1016/j.ejps.2024.106995_bib0042) 2016; 225 Christensen (10.1016/j.ejps.2024.106995_bib0011) 2011; 10 Van Pinxteren (10.1016/j.ejps.2024.106995_bib0071) 2000; 30 Tsai (10.1016/j.ejps.2024.106995_bib0069) 2006; 8 Alter (10.1016/j.ejps.2024.106995_bib0004) 2018; 39 Li (10.1016/j.ejps.2024.106995_bib0038) 2014; 62 Lu (10.1016/j.ejps.2024.106995_bib0044) 2021; 36 Li (10.1016/j.ejps.2024.106995_bib0037) 2017; 114 Lu (10.1016/j.ejps.2024.106995_bib0043) 2016; 167 Balu (10.1016/j.ejps.2024.106995_bib0005) 2011; 186 Schrager (10.1016/j.ejps.2024.106995_bib0063) 2020; 20 Davies (10.1016/j.ejps.2024.106995_bib0013) 2024; 2024 Levin (10.1016/j.ejps.2024.106995_bib0035) 2015; 11 Commandeur (10.1016/j.ejps.2024.106995_bib0012) 2013; 190 Guirado (10.1016/j.ejps.2024.106995_bib0022) 2006; 8 Hadinoto (10.1016/j.ejps.2024.106995_bib0023) 2013; 85 Liu (10.1016/j.ejps.2024.106995_bib0041) 2016; 8 Fabrizi (10.1016/j.ejps.2024.106995_bib0016) 2006; 24 Lin (10.1016/j.ejps.2024.106995_bib0039) 2012; 28 Boom (10.1016/j.ejps.2024.106995_bib0007) 2007; 117 Woodworth (10.1016/j.ejps.2024.106995_bib0075) 2008; 181 Schnyder (10.1016/j.ejps.2024.106995_bib0062) 2021; 41 10.1016/j.ejps.2024.106995_bib0055 You (10.1016/j.ejps.2024.106995_bib0076) 2012; 75 Leone (10.1016/j.ejps.2024.106995_bib0034) 2019; 134 Lewinsohn (10.1016/j.ejps.2024.106995_bib0036) 2017; 8 10.1016/j.ejps.2024.106995_bib0059 Maglione (10.1016/j.ejps.2024.106995_bib0045) 2007; 178 Szachniewicz (10.1016/j.ejps.2024.106995_bib0064) 2024; 666 Geluk (10.1016/j.ejps.2024.106995_bib0018) 2012; 30 Phuah (10.1016/j.ejps.2024.106995_bib0052) 2016; 84 Khademi (10.1016/j.ejps.2024.106995_bib0030) 2018; 125 Ogai (10.1016/j.ejps.2024.106995_bib0048) 2018; 24 Grace (10.1016/j.ejps.2024.106995_bib0021) 2021; 12 Sah (10.1016/j.ejps.2024.106995_bib0060) 2013; 8 Lindenstrøm (10.1016/j.ejps.2024.106995_bib0040) 2009; 182 (10.1016/j.ejps.2024.106995_bib0073) 2023 Harari (10.1016/j.ejps.2024.106995_bib0024) 2011; 3 Kashem (10.1016/j.ejps.2024.106995_bib0029) 2017; 35 Henao-Tamayo (10.1016/j.ejps.2024.106995_bib0025) 2010; 17 Moyle (10.1016/j.ejps.2024.106995_bib0047) 2013; 8 Khademi (10.1016/j.ejps.2024.106995_bib0031) 2018; 126 Turner (10.1016/j.ejps.2024.106995_bib0070) 2001; 36 Giles (10.1016/j.ejps.2024.106995_bib0020) 2015; 195 Trunz (10.1016/j.ejps.2024.106995_bib0068) 2006; 367 Rijnink (10.1016/j.ejps.2024.106995_bib0056) 2021; 12 Szachniewicz (10.1016/j.ejps.2024.106995_bib78) 2025; 145 Torrado (10.1016/j.ejps.2024.106995_bib0067) 2013; 8 Prezzemolo (10.1016/j.ejps.2024.106995_bib0054) 2014; 5 Szachniewicz (10.1016/j.ejps.2024.106995_bib0066) 2024; 203 Roy (10.1016/j.ejps.2024.106995_bib0058) 2005; 73 Zimmermann (10.1016/j.ejps.2024.106995_bib0077) 2016; 8 Moon (10.1016/j.ejps.2024.106995_bib0046) 2012; 7 Witting (10.1016/j.ejps.2024.106995_bib0074) 2000; 84 Egunsola (10.1016/j.ejps.2024.106995_bib0015) 2021; 4 Ottenhoff (10.1016/j.ejps.2024.106995_bib0049) 2012; 8 Schnyder (10.1016/j.ejps.2024.106995_bib0061) 2020; 37 Aagaard (10.1016/j.ejps.2024.106995_bib0001) 2011; 2 Franken (10.1016/j.ejps.2024.106995_bib0017) 2000; 18 10.1016/j.ejps.2024.106995_bib0050 Joosten (10.1016/j.ejps.2024.106995_bib0027) 2016; 12 Ghitman (10.1016/j.ejps.2024.106995_bib0019) 2020; 193 Johnson (10.1016/j.ejps.2024.106995_bib0026) 1997; 78 Vordermeier (10.1016/j.ejps.2024.106995_bib0072) 2003; 106 Bosio (10.1016/j.ejps.2024.106995_bib0008) 2000; 164 |
| References_xml | – volume: 24 start-page: 497 year: 2006 end-page: 506 ident: bib0016 article-title: Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease publication-title: Aliment. Pharmacol. Ther. – volume: 7 start-page: e31472 year: 2012 ident: bib0046 article-title: Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine publication-title: PLoS. One – volume: 3 start-page: 372 year: 2011 end-page: 376 ident: bib0024 article-title: Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease publication-title: Nat. Med. – volume: 114 start-page: 5023 year: 2017 end-page: 5028 ident: bib0037 article-title: Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis publication-title: Proc. Natl. Acad. Sci. u S. a – volume: 84 start-page: 1301 year: 2016 end-page: 1311 ident: bib0052 article-title: Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques publication-title: Infect. Immun. – volume: 271 start-page: 88 year: 2018 end-page: 97 ident: bib0057 article-title: A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522 publication-title: J. Control Release – reference: R Core Team, 2023. R: A language and environment for statistical computing. – volume: 84 start-page: 407 year: 2000 end-page: 412 ident: bib0074 article-title: Intramuscular and intradermal injection of capsaicin: a comparison of local and referred pain publication-title: Pain. – volume: 4 year: 2021 ident: bib0015 article-title: Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis publication-title: JAMa Netw. Open. – volume: 20 start-page: 95 year: 2015 end-page: 104 ident: bib0051 article-title: Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives publication-title: Drug Discov. Today – volume: 12 year: 2021 ident: bib0021 publication-title: Antibody Subclass and Glycosylation Shift Following Effective TB Treatment. Front Immunol – volume: 35 start-page: 469 year: 2017 end-page: 499 ident: bib0029 article-title: Antigen-Presenting Cells in the Skin publication-title: Annu. Rev. Immunol. – volume: 182 start-page: 8047 year: 2009 end-page: 8055 ident: bib0040 article-title: Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells publication-title: J. Immunol. – volume: 367 start-page: 1173 year: 2006 end-page: 1180 ident: bib0068 article-title: Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness publication-title: Lancet – volume: 8 start-page: 218 year: 2006 end-page: 232 ident: bib0069 article-title: Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension publication-title: Cell Microbiol. – volume: 186 start-page: 3113 year: 2011 end-page: 3119 ident: bib0005 article-title: A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis publication-title: J. Immunol. – volume: 62 start-page: 86 year: 2014 end-page: 95 ident: bib0038 article-title: A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice publication-title: Mol. Immunol. – volume: 181 start-page: 8595 year: 2008 end-page: 8603 ident: bib0075 article-title: Mycobacterium tuberculosis-Specific CD8+ T Cells Require Perforin to Kill Target Cells and Provide Protection In Vivo publication-title: J. Immunol. – volume: 139 year: 2023 ident: bib0014 article-title: Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant publication-title: Tuberculosis – volume: 73 start-page: 6101 year: 2005 end-page: 6109 ident: bib0058 article-title: Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice publication-title: Infect. Immun. – volume: 8 start-page: 11969 year: 2016 end-page: 11979 ident: bib0041 article-title: Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses publication-title: ACS. Appl. Mater. Interfaces. – volume: 2 start-page: 189 year: 2011 end-page: 194 ident: bib0001 article-title: A multistage tuberculosis vaccine that confers efficient protection before and after exposure publication-title: Nat. Med. – volume: 181 start-page: 508 year: 2012 end-page: 514 ident: bib0053 article-title: Activated B Cells in the Granulomas of Nonhuman Primates Infected with Mycobacterium tuberculosis publication-title: Am. J. Pathol. – volume: 20 start-page: e28 year: 2020 end-page: e37 ident: bib0063 article-title: The status of tuberculosis vaccine development publication-title: Lancet Infect. Dis. – volume: 666 year: 2024 ident: bib0064 article-title: Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model – A comparison publication-title: Int. J. Pharm. – volume: 37 year: 2020 ident: bib0061 article-title: Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis publication-title: Travel. Med. Infect. Dis. – volume: 12 year: 2016 ident: bib0027 article-title: Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment publication-title: PLoS. Pathog. – volume: 134 start-page: 49 year: 2019 end-page: 59 ident: bib0034 article-title: Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment publication-title: Eur. J. Pharm. Biopharm. – volume: 8 start-page: 360 year: 2013 end-page: 376 ident: bib0047 article-title: Modern Subunit Vaccines: Development, Components, and Research Opportunities publication-title: ChemMedChem. – volume: 17 start-page: 618 year: 2010 end-page: 625 ident: bib0025 article-title: Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with mycobacterium tuberculosis publication-title: Clin. Vaccine Immunol. – volume: 8 start-page: 747 year: 2013 end-page: 765 ident: bib0060 article-title: Concepts and practices used to develop functional PLGA-based nanoparticulate systems publication-title: Int. J. Nanomedicine – volume: 75 start-page: 77 year: 2012 end-page: 84 ident: bib0076 article-title: Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 Fusion Protein, but Not an Adenovirus-Based Vaccine, Protects Mice Against Intravenous Challenge with Mycobacterium tuberculosis publication-title: Scand. J. Immunol. – volume: 85 start-page: 427 year: 2013 end-page: 443 ident: bib0023 article-title: Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review publication-title: Eur. J. Pharm. Biopharm. – volume: 78 start-page: 257 year: 1997 end-page: 261 ident: bib0026 article-title: Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice publication-title: Tuberc Lung Dis – volume: 145 year: 2025 ident: bib78 article-title: Cationic pH-sensitive liposomes as tuberculosis subunit vaccine delivery systems: Effect of liposome composition on cellular innate immune responses publication-title: Int. Immunopharmacol. – volume: 195 year: 2024 ident: bib0065 article-title: Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol publication-title: Eur. J. Pharm. Sci. – volume: 181 start-page: 1407 year: 2012 end-page: 1417 ident: bib0002 article-title: The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults publication-title: Am. J. Respir. Crit. Care Med. – volume: 167 start-page: 433 year: 2016 end-page: 443.e14 ident: bib0043 article-title: A Functional Role for Antibodies in Tuberculosis publication-title: Cell – volume: 8 start-page: e61681 year: 2013 ident: bib0067 article-title: Differential and Site Specific Impact of B Cells in the Protective Immune Response to Mycobacterium tuberculosis in the Mouse publication-title: PLoS. One – volume: 30 start-page: 3689 year: 2000 end-page: 3698 ident: bib0071 article-title: Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells publication-title: Eur. J. Immunol. – volume: 8 year: 2012 ident: bib0049 article-title: Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? publication-title: PLoS. Pathog. – volume: 39 start-page: 102 year: 2018 end-page: 110 ident: bib0004 article-title: Antibody glycosylation in inflammation, disease and vaccination publication-title: Semin. Immunol. – volume: 36 year: 2021 ident: bib0044 article-title: CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection publication-title: Cell Rep. – volume: 195 start-page: 2900 year: 2015 end-page: 2907 ident: bib0032 article-title: Role of B Cells in Mucosal Vaccine–Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis publication-title: J. Immunol. – volume: 24 start-page: 630 year: 2018 end-page: 635 ident: bib0048 article-title: Enhanced immunity in intradermal vaccination by novel hollow microneedles publication-title: Skin. Res. Technol. – year: 2023 ident: bib0073 article-title: Global Tuberculosis Report 2023 – volume: 14 start-page: 2728 year: 2022 ident: bib0003 article-title: PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases publication-title: Pharmaceutics. – volume: 2024 start-page: 1 year: 2024 end-page: 13 ident: bib0013 article-title: Age and sex influence antibody profiles associated with tuberculosis progression publication-title: Nat. Microbiol. – volume: 30 start-page: 7513 year: 2012 end-page: 7521 ident: bib0018 article-title: A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice publication-title: Vaccine – volume: 8 year: 2017 ident: bib0036 article-title: Polyfunctional CD4+ T cells as targets for tuberculosis vaccination publication-title: Front. Immunol. – volume: 195 start-page: 2571 year: 2015 end-page: 2579 ident: bib0020 article-title: B Cell–Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus publication-title: J. Immunol. – volume: 12 year: 2021 ident: bib0056 article-title: B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis publication-title: Front. Immunol. – volume: 8 start-page: 1325 year: 2016 end-page: 1339 ident: bib0077 article-title: Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis publication-title: EMBo Mol. Med. – volume: 73 start-page: 7759 year: 2005 ident: bib0033 article-title: Memory T Lymphocytes Generated by Mycobacterium bovis BCG Vaccination Reside within a CD4 CD44lo CD62 Ligandhi Population publication-title: Infect. Immun. – year: 2012 ident: bib0010 article-title: Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis publication-title: Pulm. Med. – volume: 117 start-page: 2092 year: 2007 end-page: 2094 ident: bib0007 article-title: New TB vaccines: is there a requirement for CD8+ T cells? publication-title: J. Clin. Invest. – volume: 225 start-page: 230 year: 2016 end-page: 239 ident: bib0042 article-title: Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles publication-title: J. Control Release – volume: 31 start-page: S64 year: 2000 end-page: S67 ident: bib0009 article-title: Preventing Tuberculosis with Bacillus Calmette-Guérin Vaccine: A Meta-Analysis of the Literature publication-title: Clin. Infect. Dis. – reference: Ottenhoff, T.H.M., Lewinsohn, D.A., Lewinsohn, D.M., 2008. Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis: Antigen Specificity, Function, Implications and Applications. Handbook of Tuberculosis 119–155. – volume: 220 year: 2023 ident: bib0006 article-title: A half-century of research on tuberculosis: Successes and challenges publication-title: J. Exp. Med. – volume: 126 start-page: 509 year: 2018 end-page: 514 ident: bib0031 article-title: Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant publication-title: APMIS – volume: 178 start-page: 7222 year: 2007 end-page: 7234 ident: bib0045 article-title: B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis publication-title: J. Immunol. – volume: 190 start-page: 1659 year: 2013 end-page: 1671 ident: bib0012 article-title: An Unbiased Genome-Wide Mycobacterium tuberculosis Gene Expression Approach To Discover Antigens Targeted by Human T Cells Expressed during Pulmonary Infection publication-title: J. Immunol. – volume: 193 year: 2020 ident: bib0019 article-title: Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine publication-title: Mater. Des. – reference: RStudio Team, 2023. RStudio: Integrated Development Environment for R. – volume: 8 start-page: 1252 year: 2006 end-page: 1259 ident: bib0022 article-title: Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice publication-title: Microbes. Infect. – volume: 28 start-page: 1693 year: 2012 end-page: 1702 ident: bib0039 article-title: CD4 T Cell Depletion Exacerbates Acute Mycobacterium tuberculosis While Reactivation of Latent Infection Is Dependent on Severity of Tissue Depletion in Cynomolgus Macaques publication-title: AIDS Res. Hum. Retroviruses – volume: 203 year: 2024 ident: bib0066 article-title: Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis publication-title: Eur. J. Pharm. Biopharm. – volume: 112 start-page: 20 year: 2017 end-page: 29 ident: bib0028 article-title: Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design publication-title: Microb. Pathog. – reference: . – volume: 41 year: 2021 ident: bib0062 article-title: Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review publication-title: Travel. Med. Infect. Dis. – volume: 10 start-page: 513 year: 2011 end-page: 521 ident: bib0011 article-title: Cationic liposomes as vaccine adjuvants publication-title: Expert. Rev. Vaccines. – volume: 164 start-page: 6417 year: 2000 end-page: 6425 ident: bib0008 article-title: Infection of B Cell-Deficient Mice with CDC 1551, a Clinical Isolate of Mycobacterium tuberculosis: Delay in Dissemination and Development of Lung Pathology publication-title: J. Immunol. – volume: 5 start-page: 83298 year: 2014 ident: bib0054 article-title: Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis publication-title: Front. Immunol. – volume: 106 start-page: 312 year: 2003 end-page: 316 ident: bib0072 article-title: Increase of tuberculous infection in the organs of B cell-deficient mice publication-title: Clin. Exp. Immunol. – volume: 36 start-page: 537 year: 2001 end-page: 545 ident: bib0070 article-title: The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4 publication-title: Exp. Gerontol. – volume: 18 start-page: 95 year: 2000 end-page: 99 ident: bib0017 article-title: Purification of His-Tagged Proteins by Immobilized Chelate Affinity Chromatography: The Benefits from the Use of Organic Solvent publication-title: Protein Expr. Purif. – volume: 125 start-page: 507 year: 2018 end-page: 513 ident: bib0030 article-title: A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity publication-title: Microb. Pathog. – volume: 11 start-page: 27 year: 2015 end-page: 36 ident: bib0035 article-title: Tailored immunity by skin antigen-presenting cells publication-title: Hum. Vaccin. ImmunOther – volume: 203 year: 2024 ident: 10.1016/j.ejps.2024.106995_bib0066 article-title: Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2024.114437 – year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0010 article-title: Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis publication-title: Pulm. Med. doi: 10.1155/2012/745483 – volume: 4 year: 2021 ident: 10.1016/j.ejps.2024.106995_bib0015 article-title: Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis publication-title: JAMa Netw. Open. doi: 10.1001/jamanetworkopen.2020.35693 – volume: 220 year: 2023 ident: 10.1016/j.ejps.2024.106995_bib0006 article-title: A half-century of research on tuberculosis: Successes and challenges publication-title: J. Exp. Med. doi: 10.1084/jem.20230859 – volume: 36 year: 2021 ident: 10.1016/j.ejps.2024.106995_bib0044 article-title: CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.109696 – volume: 78 start-page: 257 year: 1997 ident: 10.1016/j.ejps.2024.106995_bib0026 article-title: Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice publication-title: Tuberc Lung Dis doi: 10.1016/S0962-8479(97)90006-X – volume: 30 start-page: 7513 year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0018 article-title: A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice publication-title: Vaccine doi: 10.1016/j.vaccine.2012.10.045 – volume: 193 year: 2020 ident: 10.1016/j.ejps.2024.106995_bib0019 article-title: Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine publication-title: Mater. Des. doi: 10.1016/j.matdes.2020.108805 – volume: 225 start-page: 230 year: 2016 ident: 10.1016/j.ejps.2024.106995_bib0042 article-title: Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles publication-title: J. Control Release doi: 10.1016/j.jconrel.2016.01.050 – volume: 167 start-page: 433 year: 2016 ident: 10.1016/j.ejps.2024.106995_bib0043 article-title: A Functional Role for Antibodies in Tuberculosis publication-title: Cell doi: 10.1016/j.cell.2016.08.072 – volume: 271 start-page: 88 year: 2018 ident: 10.1016/j.ejps.2024.106995_bib0057 article-title: A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522 publication-title: J. Control Release doi: 10.1016/j.jconrel.2017.12.003 – volume: 10 start-page: 513 year: 2011 ident: 10.1016/j.ejps.2024.106995_bib0011 article-title: Cationic liposomes as vaccine adjuvants publication-title: Expert. Rev. Vaccines. doi: 10.1586/erv.11.17 – volume: 367 start-page: 1173 year: 2006 ident: 10.1016/j.ejps.2024.106995_bib0068 article-title: Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness publication-title: Lancet doi: 10.1016/S0140-6736(06)68507-3 – volume: 117 start-page: 2092 year: 2007 ident: 10.1016/j.ejps.2024.106995_bib0007 article-title: New TB vaccines: is there a requirement for CD8+ T cells? publication-title: J. Clin. Invest. doi: 10.1172/JCI32933 – volume: 8 start-page: 1252 year: 2006 ident: 10.1016/j.ejps.2024.106995_bib0022 article-title: Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice publication-title: Microbes. Infect. doi: 10.1016/j.micinf.2005.12.004 – volume: 85 start-page: 427 year: 2013 ident: 10.1016/j.ejps.2024.106995_bib0023 article-title: Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2013.07.002 – volume: 62 start-page: 86 year: 2014 ident: 10.1016/j.ejps.2024.106995_bib0038 article-title: A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2014.06.007 – volume: 18 start-page: 95 year: 2000 ident: 10.1016/j.ejps.2024.106995_bib0017 article-title: Purification of His-Tagged Proteins by Immobilized Chelate Affinity Chromatography: The Benefits from the Use of Organic Solvent publication-title: Protein Expr. Purif. doi: 10.1006/prep.1999.1162 – volume: 8 start-page: 11969 year: 2016 ident: 10.1016/j.ejps.2024.106995_bib0041 article-title: Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses publication-title: ACS. Appl. Mater. Interfaces. doi: 10.1021/acsami.6b01135 – volume: 73 start-page: 6101 year: 2005 ident: 10.1016/j.ejps.2024.106995_bib0058 article-title: Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice publication-title: Infect. Immun. doi: 10.1128/IAI.73.9.6101-6109.2005 – volume: 7 start-page: e31472 year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0046 article-title: Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine publication-title: PLoS. One doi: 10.1371/journal.pone.0031472 – volume: 195 year: 2024 ident: 10.1016/j.ejps.2024.106995_bib0065 article-title: Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2024.106730 – volume: 12 year: 2021 ident: 10.1016/j.ejps.2024.106995_bib0021 publication-title: Antibody Subclass and Glycosylation Shift Following Effective TB Treatment. Front Immunol – volume: 106 start-page: 312 year: 2003 ident: 10.1016/j.ejps.2024.106995_bib0072 article-title: Increase of tuberculous infection in the organs of B cell-deficient mice publication-title: Clin. Exp. Immunol. doi: 10.1046/j.1365-2249.1996.d01-845.x – volume: 182 start-page: 8047 year: 2009 ident: 10.1016/j.ejps.2024.106995_bib0040 article-title: Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells publication-title: J. Immunol. doi: 10.4049/jimmunol.0801592 – volume: 84 start-page: 1301 year: 2016 ident: 10.1016/j.ejps.2024.106995_bib0052 article-title: Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques publication-title: Infect. Immun. doi: 10.1128/IAI.00083-16 – volume: 31 start-page: S64 year: 2000 ident: 10.1016/j.ejps.2024.106995_bib0009 article-title: Preventing Tuberculosis with Bacillus Calmette-Guérin Vaccine: A Meta-Analysis of the Literature publication-title: Clin. Infect. Dis. doi: 10.1086/314072 – volume: 24 start-page: 497 year: 2006 ident: 10.1016/j.ejps.2024.106995_bib0016 article-title: Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/j.1365-2036.2006.03002.x – volume: 181 start-page: 8595 year: 2008 ident: 10.1016/j.ejps.2024.106995_bib0075 article-title: Mycobacterium tuberculosis-Specific CD8+ T Cells Require Perforin to Kill Target Cells and Provide Protection In Vivo publication-title: J. Immunol. doi: 10.4049/jimmunol.181.12.8595 – volume: 8 start-page: 1325 year: 2016 ident: 10.1016/j.ejps.2024.106995_bib0077 article-title: Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis publication-title: EMBo Mol. Med. doi: 10.15252/emmm.201606330 – volume: 14 start-page: 2728 year: 2022 ident: 10.1016/j.ejps.2024.106995_bib0003 article-title: PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases publication-title: Pharmaceutics. doi: 10.3390/pharmaceutics14122728 – volume: 195 start-page: 2571 year: 2015 ident: 10.1016/j.ejps.2024.106995_bib0020 article-title: B Cell–Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus publication-title: J. Immunol. doi: 10.4049/jimmunol.1500792 – volume: 126 start-page: 509 year: 2018 ident: 10.1016/j.ejps.2024.106995_bib0031 article-title: Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant publication-title: APMIS doi: 10.1111/apm.12851 – volume: 195 start-page: 2900 year: 2015 ident: 10.1016/j.ejps.2024.106995_bib0032 article-title: Role of B Cells in Mucosal Vaccine–Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis publication-title: J. Immunol. doi: 10.4049/jimmunol.1500981 – volume: 112 start-page: 20 year: 2017 ident: 10.1016/j.ejps.2024.106995_bib0028 article-title: Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design publication-title: Microb. Pathog. doi: 10.1016/j.micpath.2017.08.040 – volume: 8 start-page: 747 year: 2013 ident: 10.1016/j.ejps.2024.106995_bib0060 article-title: Concepts and practices used to develop functional PLGA-based nanoparticulate systems publication-title: Int. J. Nanomedicine doi: 10.2147/IJN.S40579 – volume: 39 start-page: 102 year: 2018 ident: 10.1016/j.ejps.2024.106995_bib0004 article-title: Antibody glycosylation in inflammation, disease and vaccination publication-title: Semin. Immunol. doi: 10.1016/j.smim.2018.05.003 – volume: 134 start-page: 49 year: 2019 ident: 10.1016/j.ejps.2024.106995_bib0034 article-title: Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2018.11.013 – volume: 30 start-page: 3689 year: 2000 ident: 10.1016/j.ejps.2024.106995_bib0071 article-title: Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells publication-title: Eur. J. Immunol. doi: 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4 – volume: 84 start-page: 407 year: 2000 ident: 10.1016/j.ejps.2024.106995_bib0074 article-title: Intramuscular and intradermal injection of capsaicin: a comparison of local and referred pain publication-title: Pain. doi: 10.1016/S0304-3959(99)00231-6 – volume: 28 start-page: 1693 year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0039 article-title: CD4 T Cell Depletion Exacerbates Acute Mycobacterium tuberculosis While Reactivation of Latent Infection Is Dependent on Severity of Tissue Depletion in Cynomolgus Macaques publication-title: AIDS Res. Hum. Retroviruses doi: 10.1089/aid.2012.0028 – ident: 10.1016/j.ejps.2024.106995_bib0059 – volume: 181 start-page: 1407 year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0002 article-title: The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.200910-1484OC – volume: 8 start-page: e61681 year: 2013 ident: 10.1016/j.ejps.2024.106995_bib0067 article-title: Differential and Site Specific Impact of B Cells in the Protective Immune Response to Mycobacterium tuberculosis in the Mouse publication-title: PLoS. One doi: 10.1371/journal.pone.0061681 – volume: 139 year: 2023 ident: 10.1016/j.ejps.2024.106995_bib0014 article-title: Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant publication-title: Tuberculosis doi: 10.1016/j.tube.2023.102307 – ident: 10.1016/j.ejps.2024.106995_bib0055 – volume: 145 year: 2025 ident: 10.1016/j.ejps.2024.106995_bib78 article-title: Cationic pH-sensitive liposomes as tuberculosis subunit vaccine delivery systems: Effect of liposome composition on cellular innate immune responses publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2024.113782 – volume: 181 start-page: 508 year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0053 article-title: Activated B Cells in the Granulomas of Nonhuman Primates Infected with Mycobacterium tuberculosis publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2012.05.009 – volume: 178 start-page: 7222 year: 2007 ident: 10.1016/j.ejps.2024.106995_bib0045 article-title: B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis publication-title: J. Immunol. doi: 10.4049/jimmunol.178.11.7222 – volume: 3 start-page: 372 issue: 17 year: 2011 ident: 10.1016/j.ejps.2024.106995_bib0024 article-title: Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease publication-title: Nat. Med. doi: 10.1038/nm.2299 – volume: 8 year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0049 article-title: Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? publication-title: PLoS. Pathog. doi: 10.1371/journal.ppat.1002607 – volume: 125 start-page: 507 year: 2018 ident: 10.1016/j.ejps.2024.106995_bib0030 article-title: A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity publication-title: Microb. Pathog. doi: 10.1016/j.micpath.2018.10.023 – volume: 35 start-page: 469 year: 2017 ident: 10.1016/j.ejps.2024.106995_bib0029 article-title: Antigen-Presenting Cells in the Skin publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-051116-052215 – volume: 8 start-page: 360 year: 2013 ident: 10.1016/j.ejps.2024.106995_bib0047 article-title: Modern Subunit Vaccines: Development, Components, and Research Opportunities publication-title: ChemMedChem. doi: 10.1002/cmdc.201200487 – volume: 5 start-page: 83298 year: 2014 ident: 10.1016/j.ejps.2024.106995_bib0054 article-title: Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00180 – volume: 41 year: 2021 ident: 10.1016/j.ejps.2024.106995_bib0062 article-title: Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review publication-title: Travel. Med. Infect. Dis. doi: 10.1016/j.tmaid.2021.102007 – ident: 10.1016/j.ejps.2024.106995_bib0050 doi: 10.1002/9783527611614.ch23 – volume: 75 start-page: 77 year: 2012 ident: 10.1016/j.ejps.2024.106995_bib0076 article-title: Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 Fusion Protein, but Not an Adenovirus-Based Vaccine, Protects Mice Against Intravenous Challenge with Mycobacterium tuberculosis publication-title: Scand. J. Immunol. doi: 10.1111/j.1365-3083.2011.02629.x – year: 2023 ident: 10.1016/j.ejps.2024.106995_bib0073 – volume: 2 start-page: 189 issue: 17 year: 2011 ident: 10.1016/j.ejps.2024.106995_bib0001 article-title: A multistage tuberculosis vaccine that confers efficient protection before and after exposure publication-title: Nat. Med. doi: 10.1038/nm.2285 – volume: 36 start-page: 537 year: 2001 ident: 10.1016/j.ejps.2024.106995_bib0070 article-title: The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4 publication-title: Exp. Gerontol. doi: 10.1016/S0531-5565(00)00257-6 – volume: 8 start-page: 218 year: 2006 ident: 10.1016/j.ejps.2024.106995_bib0069 article-title: Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension publication-title: Cell Microbiol. doi: 10.1111/j.1462-5822.2005.00612.x – volume: 164 start-page: 6417 year: 2000 ident: 10.1016/j.ejps.2024.106995_bib0008 article-title: Infection of B Cell-Deficient Mice with CDC 1551, a Clinical Isolate of Mycobacterium tuberculosis: Delay in Dissemination and Development of Lung Pathology publication-title: J. Immunol. doi: 10.4049/jimmunol.164.12.6417 – volume: 11 start-page: 27 year: 2015 ident: 10.1016/j.ejps.2024.106995_bib0035 article-title: Tailored immunity by skin antigen-presenting cells publication-title: Hum. Vaccin. ImmunOther doi: 10.4161/hv.34299 – volume: 2024 start-page: 1 year: 2024 ident: 10.1016/j.ejps.2024.106995_bib0013 article-title: Age and sex influence antibody profiles associated with tuberculosis progression publication-title: Nat. Microbiol. – volume: 20 start-page: 95 year: 2015 ident: 10.1016/j.ejps.2024.106995_bib0051 article-title: Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2014.09.018 – volume: 73 start-page: 7759 year: 2005 ident: 10.1016/j.ejps.2024.106995_bib0033 article-title: Memory T Lymphocytes Generated by Mycobacterium bovis BCG Vaccination Reside within a CD4 CD44lo CD62 Ligandhi Population publication-title: Infect. Immun. doi: 10.1128/IAI.73.11.7759-7764.2005 – volume: 12 year: 2021 ident: 10.1016/j.ejps.2024.106995_bib0056 article-title: B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.640168 – volume: 12 year: 2016 ident: 10.1016/j.ejps.2024.106995_bib0027 article-title: Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment publication-title: PLoS. Pathog. doi: 10.1371/journal.ppat.1005687 – volume: 666 year: 2024 ident: 10.1016/j.ejps.2024.106995_bib0064 article-title: Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model – A comparison publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2024.124842 – volume: 186 start-page: 3113 year: 2011 ident: 10.1016/j.ejps.2024.106995_bib0005 article-title: A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis publication-title: J. Immunol. doi: 10.4049/jimmunol.1003189 – volume: 8 year: 2017 ident: 10.1016/j.ejps.2024.106995_bib0036 article-title: Polyfunctional CD4+ T cells as targets for tuberculosis vaccination publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.01262 – volume: 17 start-page: 618 year: 2010 ident: 10.1016/j.ejps.2024.106995_bib0025 article-title: Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with mycobacterium tuberculosis publication-title: Clin. Vaccine Immunol. doi: 10.1128/CVI.00368-09 – volume: 37 year: 2020 ident: 10.1016/j.ejps.2024.106995_bib0061 article-title: Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis publication-title: Travel. Med. Infect. Dis. doi: 10.1016/j.tmaid.2020.101868 – volume: 20 start-page: e28 year: 2020 ident: 10.1016/j.ejps.2024.106995_bib0063 article-title: The status of tuberculosis vaccine development publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(19)30625-5 – volume: 190 start-page: 1659 year: 2013 ident: 10.1016/j.ejps.2024.106995_bib0012 article-title: An Unbiased Genome-Wide Mycobacterium tuberculosis Gene Expression Approach To Discover Antigens Targeted by Human T Cells Expressed during Pulmonary Infection publication-title: J. Immunol. doi: 10.4049/jimmunol.1201593 – volume: 24 start-page: 630 year: 2018 ident: 10.1016/j.ejps.2024.106995_bib0048 article-title: Enhanced immunity in intradermal vaccination by novel hollow microneedles publication-title: Skin. Res. Technol. doi: 10.1111/srt.12576 – volume: 114 start-page: 5023 year: 2017 ident: 10.1016/j.ejps.2024.106995_bib0037 article-title: Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis publication-title: Proc. Natl. Acad. Sci. u S. a doi: 10.1073/pnas.1611776114 |
| SSID | ssj0006870 |
| Score | 2.4503312 |
| Snippet | Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine,... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 106995 |
| SubjectTerms | Adjuvant Animals Antigens, Bacterial - administration & dosage Antigens, Bacterial - immunology Bacillus Calmette-Guérin Bacterial Proteins - administration & dosage Bacterial Proteins - immunology Cationic lipid−PLGA hybrid nanoparticles Female Immunogenicity Injections, Intradermal Injections, Subcutaneous Lipids - chemistry Mice Mice, Inbred C57BL Nanoparticles - administration & dosage Nanoparticles - chemistry Polylactic Acid-Polyglycolic Acid Copolymer - administration & dosage Polylactic Acid-Polyglycolic Acid Copolymer - chemistry Subunit vaccine Tuberculosis Tuberculosis - immunology Tuberculosis - prevention & control Tuberculosis Vaccines - administration & dosage Tuberculosis Vaccines - chemistry Tuberculosis Vaccines - immunology Vaccine delivery system |
| Title | Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine |
| URI | https://dx.doi.org/10.1016/j.ejps.2024.106995 https://www.ncbi.nlm.nih.gov/pubmed/39710106 https://www.proquest.com/docview/3148495092 |
| Volume | 205 |
| WOSCitedRecordID | wos001394650900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1879-0720 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006870 issn: 0928-0987 databaseCode: DOA dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1879-0720 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006870 issn: 0928-0987 databaseCode: AIEXJ dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1879-0720 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006870 issn: 0928-0987 databaseCode: AIEXJ dateStart: 19950201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9owFLYo3cNept3HLsiTJl7SVLkYEu8NVXRrxxhSqcRb5DhOC0KBAWGl_2D_bj9px7FzYWur7mEvETJxYun7cs7x8bkg9MGLBGg5n5ixdG4Qblmmz2PXdIkraBgx0PIsazbhDQb-eEyHtdqvPBdmM_OSxL-6oov_CjWMAdgydfYf4C4eCgPwG0CHK8AO13sBfyLdtZEUuDNDxlykK2OVhjwFK1DIeNdJlhFyXUR19MqIDrZTSddYzmUQQZp5E5gxmywmkTnsf-oal1uZ52UkLIEtt1qBsU5DseTpbC4rnGwYLw7sb3L7axN4cbnjUNfauLDyz66ZLDArfkx45ub-WrpuZdYVSEyjJ7TcPDNOyyDlTXYCNZleMLbU_38pUy6yPvX5aB-eelR1fTjtPFq6kNa-JzOwHHWwI24Y0yLesdoVIQ27YKo6e_6lP5QrY3oopgtZy90hh-XNu8W6B9-C4_N-Pxj1xqPW4rsp-5jJ837d1GUP7Ttem_p1tN896Y1PC-ug42cNDItl6kQuFXP452tvM5Zu2wxlRtHoMXqkdzO4qzjwBNVE8hS1hgrW7QEeldl9qwPcwsOyUPr2GfpZoSpWVMVVquIqVT9iTVQ8j_EuUXFGVJwRFTNcEhUrouIqUXGVqFgT9Tk6P-6Njj6bujWIyUHprM04pDYjzCIgV9wwjJmIQocySiMC44J1YB8Qgx4XnTimoc-IbJvgk7YA892m3HVfoHoyT8QrhKkXcovEtt0JXcJB_wvSIaFvceJwy4k7DWTnGARc182X7VtmQR4gOQ0kboHELVC4NZBRzFmoqjF33t3OoQ30l6bs2QBoeee89zkPAlAK8qRPwRO4NvEJhb2A00AvFUGKdYBotqUj6PU9Zr9BD8vv7i2qr5epeIce8M16slo20Z439pua4M3Mm_UbYeDqhA |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intradermal+versus+subcutaneous+immunization%3A+Effects+of+administration+route+using+a+lipid-PLGA+hybrid+nanoparticle+tuberculosis+vaccine&rft.jtitle=European+journal+of+pharmaceutical+sciences&rft.au=Szachniewicz%2C+M+M&rft.au=van+den+Eeden%2C+S+J+F&rft.au=van+Meijgaarden%2C+K+E&rft.au=Franken%2C+K+L+M+C&rft.date=2025-02-01&rft.issn=1879-0720&rft.eissn=1879-0720&rft.volume=205&rft.spage=106995&rft_id=info:doi/10.1016%2Fj.ejps.2024.106995&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-0987&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-0987&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-0987&client=summon |